Developments toward the Implementation of 44Sc Production at a Medical Cyclotron

van der Meulen, Nicholas P.; Hasler, Roger; Talip, Zeynep; Grundler, Pascal V.; Favaretto, Chiara; Umbricht, Christoph A.; Müller, Cristina; Dellepiane, Gaia; Carzaniga, Tommaso S.; Braccini, Saverio

doi:10.3390/molecules25204706

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessArticle

Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron

Nicholas P. van der Meulen

^1,2,*

²,

²,

Christoph A. Umbricht

²,

³,

and

Laboratory of Radiochemistry, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland

Center of Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland

Albert Einstein Center for Fundamental Physics, Laboratory of High Energy Physics, University of Bern, 3012 Bern, Switzerland

Author to whom correspondence should be addressed.

Academic Editors: Anne Roivainen and Xiang-Guo Li

Molecules 2020, 25(20), 4706; https://doi.org/10.3390/molecules25204706

Received: 2 September 2020 / Revised: 26 September 2020 / Accepted: 29 September 2020 / Published: 14 October 2020

(This article belongs to the Special Issue Radiopharmaceuticals for PET Imaging - Issue B)

View Full-Text Download PDF

Browse Figures

Citation Export

Abstract

⁴⁴Sc has favorable properties for cancer diagnosis using Positron Emission Tomography (PET) making it a promising candidate for application in nuclear medicine. The implementation of its production with existing compact medical cyclotrons would mean the next essential milestone in the development of this radionuclide. While the production and application of ⁴⁴Sc has been comprehensively investigated, the development of specific targetry and irradiation methods is of paramount importance. As a result, the target was optimized for the ⁴⁴Ca(p,n)⁴⁴Sc nuclear reaction using CaO instead of CaCO₃, ensuring decrease in target radioactive degassing during irradiation and increased radionuclidic yield. Irradiations were performed at the research cyclotron at the Paul Scherrer Institute (~11 MeV, 50 µA, 90 min) and the medical cyclotron at the University of Bern (~13 MeV, 10 µA, 240 min), with yields varying from 200 MBq to 16 GBq. The development of targetry, chemical separation as well as the practical issues and implications of irradiations, are analyzed and discussed. As a proof-of-concept study, the ⁴⁴Sc produced at the medical cyclotron was used for a preclinical study using a previously developed albumin-binding prostate-specific membrane antigen (PSMA) ligand. This work demonstrates the feasibility to produce ⁴⁴Sc with high yields and radionuclidic purity using a medical cyclotron, equipped with a commercial solid target station. View Full-Text

Keywords: scandium-44; ion exchange chromatography; medical cyclotron

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

Supplementary File 1:
PDF-Document (PDF, 1720 KiB)

Share and Cite

MDPI and ACS Style

van der Meulen, N.P.; Hasler, R.; Talip, Z.; Grundler, P.V.; Favaretto, C.; Umbricht, C.A.; Müller, C.; Dellepiane, G.; Carzaniga, T.S.; Braccini, S. Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron. Molecules 2020, 25, 4706. https://doi.org/10.3390/molecules25204706

AMA Style

van der Meulen NP, Hasler R, Talip Z, Grundler PV, Favaretto C, Umbricht CA, Müller C, Dellepiane G, Carzaniga TS, Braccini S. Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron. Molecules. 2020; 25(20):4706. https://doi.org/10.3390/molecules25204706

Chicago/Turabian Style

van der Meulen, Nicholas P., Roger Hasler, Zeynep Talip, Pascal V. Grundler, Chiara Favaretto, Christoph A. Umbricht, Cristina Müller, Gaia Dellepiane, Tommaso S. Carzaniga, and Saverio Braccini. 2020. "Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron" Molecules 25, no. 20: 4706. https://doi.org/10.3390/molecules25204706

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron

Abstract

Supplementary Material

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI